Downloads: 267

Files in This Item:
File Description SizeFormat 
j.chom.2022.10.003.pdf5.73 MBAdobe PDFView/Open
Title: Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
Authors: Saito, Akatsuki
Tamura, Tomokazu
Zahradnik, Jiri
Deguchi, Sayaka
Tabata, Koshiro
Anraku, Yuki
Kimura, Izumi
Ito, Jumpei
Yamasoba, Daichi
Nasser, Hesham
Toyoda, Mako
Nagata, Kayoko
Uriu, Keiya
Kosugi, Yusuke
Fujita, Shigeru
Shofa, Maya
Monira Begum, M.S.T.
Shimizu, Ryo
Oda, Yoshitaka
Suzuki, Rigel
Ito, Hayato
Nao, Naganori
Wang, Lei
Tsuda, Masumi
Yoshimatsu, Kumiko
Kuramochi, Jin
Kita, Shunsuke
Sasaki-Tabata, Kaori
Fukuhara, Hideo
Maenaka, Katsumi
Yamamoto, Yuki
Nagamoto, Tetsuharu
Asakura, Hiroyuki
Nagashima, Mami
Sadamasu, Kenji
Yoshimura, Kazuhisa
Ueno, Takamasa
Schreiber, Gideon
Takaori-Kondo, Akifumi
The Genotype to Phenotype Japan (G2P-Japan) Consortium
Shirakawa, Kotaro  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-7469-1276 (unconfirmed)
Sawa, Hirofumi
Irie, Takashi
Hashiguchi, Takao  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0001-7578-7571 (unconfirmed)
Takayama, Kazuo  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-1132-2457 (unconfirmed)
Matsuno, Keita
Tanaka, Shinya
Ikeda, Terumasa
Fukuhara, Takasuke
Sato, Kei
Author's alias: 齊藤, 暁
田村, 友和
出口, 清香
田畑, 耕史郎
安楽, 佑樹
木村, 出海
伊東, 潤平
山岨, 大智
豊田, 真子
永田, 佳代子
瓜生, 慧也
小杉, 優介
藤田, 滋
清水, 凌
小田, 義崇
鈴木, 理滋
伊藤, 駿
直, 亨則
王, 磊
津田, 真寿美
吉松, 組子
倉持, 仁
喜多, 俊介
田畑, 香織
福原, 秀雄
前仲, 勝実
山本, 佑樹
永元, 哲治
浅倉, 弘幸
長島, 真美
貞升, 健志
吉村, 和久
上野, 貴将
高折, 晃史
白川, 康太郎
澤, 洋文
入江, 崇
橋口, 隆生
高山, 和雄
松野, 啓太
田中, 伸哉
池田, 輝政
福原, 崇介
佐藤, 佳
Keywords: SARS-CoV-2
COVID-19
Omicron
BA.2.75
transmissibility
immune resistance
antiviral drug resistance
pathogenicity
Issue Date: 9-Nov-2022
Publisher: Elsevier BV
Cell Press
Journal title: Cell Host and Microbe
Volume: 30
Issue: 11
Start page: 1540
End page: 1555
Thesis number: e15
Abstract: The SARS-CoV-2 Omicron BA.2.75 variant emerged in May 2022. BA.2.75 is a BA.2 descendant but is phylogenetically distinct from BA.5, the currently predominant BA.2 descendant. Here, we show that BA.2.75 has a greater effective reproduction number and different immunogenicity profile than BA.5. We determined the sensitivity of BA.2.75 to vaccinee and convalescent sera as well as a panel of clinically available antiviral drugs and antibodies. Antiviral drugs largely retained potency but antibody sensitivity varied depending on several key BA.2.75-specific substitutions. The BA.2.75 spike exhibited a profoundly higher affinity for its human receptor, ACE2. Additionally, the fusogenicity, growth efficiency in human alveolar epithelial cells, and intrinsic pathogenicity in hamsters of BA.2.75 were greater than those of BA.2. Our multilevel investigations suggest that BA.2.75 acquired virological properties independent of BA.5, and the potential risk of BA.2.75 to global health is greater than that of BA.5.
Description: SARS-CoV-2オミクロンBA.2.75株(通称ケンタウロス)のウイルス学的性状の解明. 京都大学プレスリリース. 2022-10-12.
Rights: © 2022 The Author(s). Published by Elsevier Inc.
This is an open access article under the Creative Commons Attribution 4.0 International license.
URI: http://hdl.handle.net/2433/277087
DOI(Published Version): 10.1016/j.chom.2022.10.003
PubMed ID: 36272413
Related Link: https://www.kyoto-u.ac.jp/ja/research-news/2022-10-12-3
Appears in Collections:Journal Articles

Show full item record

Export to RefWorks


Export Format: 


This item is licensed under a Creative Commons License Creative Commons